dapsone has been researched along with Cytomegalic Inclusion Disease in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "carinii prophylaxis before the onset of AIDS: Mycobacterium avium complex disease, which developed in 33." | 1.29 | Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study. ( Anderson, R; Bacellar, H; Detels, R; Hoover, DR; Kaslow, RA; Phair, J; Saah, AJ, 1993) |
| "In MRC-5 cell cultures, the efficacy of the acyclic nucleoside ganciclovir (GCV) against human cytomegalovirus (CMV) was unaffected when combined with either amphotericin B (AMP B), ketoconazole (KCZ), dapsone (DAP), or trimethoprim/sulfamethoxazole (TMP/SMX)." | 1.29 | Efficacy of ganciclovir in combination with other antimicrobial agents against cytomegalovirus in vitro and in vivo. ( Fraser-Smith, EB; Freitas, VR; Matthews, TR, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Husain, S | 1 |
| Raza, K | 1 |
| Pilewski, JM | 1 |
| Zaldonis, D | 1 |
| Crespo, M | 1 |
| Toyoda, Y | 1 |
| Shutt, K | 1 |
| Spichty, K | 1 |
| Bentlejewski, C | 1 |
| Pakstis, DL | 1 |
| Carey, ME | 1 |
| McCurry, KR | 1 |
| Zeevi, A | 1 |
| Hoover, DR | 1 |
| Saah, AJ | 1 |
| Bacellar, H | 1 |
| Phair, J | 1 |
| Detels, R | 1 |
| Anderson, R | 1 |
| Kaslow, RA | 1 |
| Freitas, VR | 1 |
| Fraser-Smith, EB | 1 |
| Matthews, TR | 1 |
| Cheng, B | 1 |
| Hardy, WD | 2 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole and Dapsone and Their Hydroxylamine Metabolites[NCT00000826] | Phase 1 | 48 participants | Interventional | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for dapsone and Cytomegalic Inclusion Disease
| Article | Year |
|---|---|
Prophylaxis of AIDS-related opportunistic infections (OIs). Current status and future strategies.
Topics: Acquired Immunodeficiency Syndrome; Aerosols; Animals; Cryptococcosis; Cytomegalovirus Infections; D | 1991 |
Prophylaxis of AIDS-related opportunistic infections (OIs).
Topics: Acquired Immunodeficiency Syndrome; Cryptococcosis; Cytomegalovirus Infections; Dapsone; Drug Combin | 1989 |
1 trial available for dapsone and Cytomegalic Inclusion Disease
| Article | Year |
|---|---|
Prophylaxis of AIDS-related opportunistic infections (OIs). Current status and future strategies.
Topics: Acquired Immunodeficiency Syndrome; Aerosols; Animals; Cryptococcosis; Cytomegalovirus Infections; D | 1991 |
5 other studies available for dapsone and Cytomegalic Inclusion Disease
| Article | Year |
|---|---|
Experience with immune monitoring in lung transplant recipients: correlation of low immune function with infection.
Topics: Adult; Aged; Anti-Bacterial Agents; Antiviral Agents; Bacterial Infections; Cohort Studies; Cytomega | 2009 |
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifunga | 1995 |
Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Candidiasis; CD4-Positive | 1993 |
Efficacy of ganciclovir in combination with other antimicrobial agents against cytomegalovirus in vitro and in vivo.
Topics: Amphotericin B; Animals; Antifungal Agents; Antiviral Agents; Cells, Cultured; Cytomegalovirus Infec | 1993 |
Preventing opportunistic infections.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Clarithromycin; Clindamycin; Clinical Trials as To | 1995 |